Buprenorphine And Naloxone
Product Images NDC 67296-1877

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-1877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 2 mg/0.5 mg Carton Label (Image 01)

This text provides instructions on how to use Buprenorphine and Naloxone Sublingual Film, including dosage, administration techniques, storage conditions, and cautionary notes for keeping the medication out of the reach of children. It also lists the composition of each film and details the packaging and specific content of the medication. The text also suggests seeking emergency medical care in case children accidentally ingest the medication. It further mentions the equivalent quantities of buprenorphine HCl and naloxone HCl contained in each sublingual film.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 4 mg/1 mg Carton Label (Image 02)

This text provides instructions on how to use Buprenorphine and Naloxone Sublingual Film, including proper administration techniques, storing guidelines, and safety precautions. It also details the content of each film and advises to keep it out of children's reach. The product is available in pouches containing 30 sublingual films.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg Carton Label (Image 03)

This text appears to be a product label for Buprenorphine and Naloxone Sublingual Film, a medication used in opioid addiction treatment. It provides information about the storage conditions, usage instructions, emergency contact details, and additional safety warnings for the medication. This label also includes details such as the National Drug Code (NDC), lot number, expiration date, and barcode. For further details, consult a pharmacist or healthcare provider.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 12 mg/3 mg Carton Label (Image 04)

This is a description that includes information about a sublingual film containing Buprenorphine and Naloxone, with specific instructions on sublingual administration and a warning about the risks of accidental ingestion by children. The text also provides details such as National Drug Code (NDC) number, dosage equivalents, and precautions against cutting, chewing, or swallowing the sublingual film.*

FDA Label Image

Buprenorphine Hydrochloride Structrual Formula (Image 05)

FDA Label Image

Naloxone Hydrochloride Structural Formula (Image 06)

FDA Label Image

Instructions For Use Figure 1 (Image 07)

FDA Label Image

Instructions For Use Figure 2 (Image 08)

FDA Label Image

Instructions For Use Figure 3 (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.